Efficacy and safety evaluation of a new full visual range vs monofocal intraocular lens in patients with cataract: randomized, controlled Canadian clinical trial

一项针对白内障患者的随机对照临床试验,比较了一种新型全视野人工晶状体与单焦点人工晶状体的疗效和安全性。

阅读:1

Abstract

PURPOSE: To compare the visual performance and patient-reported outcomes after bilateral implantation of a new full visual range (FVR) intraocular lens (IOL) or its monofocal version. SETTING: 9 sites in Canada. DESIGN: Prospective, multicenter, randomized, double-mask, controlled study. METHODS: This study included patients who underwent bilateral implantation of either a FVR enVista Envy or monofocal MX60E IOL. Postoperative assessments included visual acuities, defocus curves, contrast sensitivity, and patient-reported outcomes using quality of vision and near activity visual questionnaire. RESULTS: The FVR IOL was noninferior to the control monofocal IOL for monocular uncorrected distance visual acuity and statistically superior to the monofocal IOL for monocular uncorrected intermediate visual acuity and uncorrected near visual acuity. Binocular defocus curves showed a range of vision of ∼4.0 diopters (D) at 0.2 logMAR or better in the FVR group. In the intermediate and near range (-1.5 to -2.5 D), the FVR group demonstrated a plateau at ∼0.1 logMAR (20/25), whereas in the monofocal group, visual acuity decreased to 0.27 logMAR (20/37) at -1.50 D defocus and to 0.48 logMAR (20/60) at -2.50 D defocus. Postoperatively, 92.7% (102/110) of the FVR patients were satisfied with their near vision, and 91.7% (99/108) of them did not require spectacles to do near-vision tasks, even for a prolonged duration. CONCLUSIONS: The FVR group exhibited a continuous range of vision from distance to near. Postoperatively, more than 90% of FVR patients were satisfied with their near vision and had no difficulty doing near-vision tasks while being spectacle-free.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。